ImpediMed Valuation
| IPDQF Stock | USD 0.04 0 12.57% |
ImpediMed seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of ImpediMed Limited from evaluating the firm fundamentals such as Return On Equity of -0.52, return on asset of -0.28, and Current Valuation of 81.27 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ImpediMed's price fluctuation is out of control at this time. Calculation of the real value of ImpediMed Limited is based on 3 months time horizon. Increasing ImpediMed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ImpediMed pink sheet is determined by what a typical buyer is willing to pay for full or partial control of ImpediMed Limited. Since ImpediMed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ImpediMed Pink Sheet. However, ImpediMed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0403 | Real 0.0341 | Hype 0.04 | Naive 0.036 |
The real value of ImpediMed Pink Sheet, also known as its intrinsic value, is the underlying worth of ImpediMed Limited Company, which is reflected in its stock price. It is based on ImpediMed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ImpediMed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ImpediMed Limited helps investors to forecast how ImpediMed pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ImpediMed more accurately as focusing exclusively on ImpediMed's fundamentals will not take into account other important factors: ImpediMed Total Value Analysis
ImpediMed Limited is currently projected to have takeover price of 81.27 M with market capitalization of 78.57 M, debt of 170 K, and cash on hands of 40.73 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ImpediMed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
81.27 M | 78.57 M | 170 K | 40.73 M |
ImpediMed Investor Information
About 14.0% of the company shares are held by company insiders. The book value of ImpediMed was currently reported as 0.03. The company recorded a loss per share of 0.01. ImpediMed Limited had not issued any dividends in recent years. The entity had 1027:1000 split on the 17th of November 2014. Based on the measurements of operating efficiency obtained from ImpediMed's historical financial statements, ImpediMed Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.ImpediMed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ImpediMed has an asset utilization ratio of 17.88 percent. This implies that the Company is making $0.18 for each dollar of assets. An increasing asset utilization means that ImpediMed Limited is more efficient with each dollar of assets it utilizes for everyday operations.ImpediMed Ownership Allocation
ImpediMed Limited has a total of 1.79 Billion outstanding shares. ImpediMed retains 13.73 (percent) of its outstanding shares held by insiders and 14.96 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.ImpediMed Profitability Analysis
The company reported the revenue of 10.49 M. Net Loss for the year was (19.87 M) with profit before overhead, payroll, taxes, and interest of 9.16 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ImpediMed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ImpediMed and how it compares across the competition.
About ImpediMed Valuation
The pink sheet valuation mechanism determines ImpediMed's current worth on a weekly basis. Our valuation model uses a comparative analysis of ImpediMed. We calculate exposure to ImpediMed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ImpediMed's related companies.ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy devices and software services in Australia, North America, and internationally. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia. Impedined operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 73 people.
8 Steps to conduct ImpediMed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ImpediMed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ImpediMed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ImpediMed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ImpediMed's revenue streams: Identify ImpediMed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ImpediMed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ImpediMed's growth potential: Evaluate ImpediMed's management, business model, and growth potential.
- Determine ImpediMed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ImpediMed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ImpediMed Growth Indicators
Investing in growth stocks can be very risky. If the company such as ImpediMed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.8 B | |
| Retained Earnings | -290.6 M | |
| Shares Float | 1.6 B |
Complementary Tools for ImpediMed Pink Sheet analysis
When running ImpediMed's price analysis, check to measure ImpediMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImpediMed is operating at the current time. Most of ImpediMed's value examination focuses on studying past and present price action to predict the probability of ImpediMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImpediMed's price. Additionally, you may evaluate how the addition of ImpediMed to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |